National Philanthropic Trust’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.39M Buy
18,602
+417
+2% +$48.8K 0.03% 160
2026
Q1
$2.19M Buy
18,185
+652
+4% +$75.3K 0.02% 154
2025
Q4
$1.85M Buy
17,533
+4,101
+31% +$385K 0.02% 175
2025
Q3
$1.13M Buy
13,432
+924
+7% +$76.1K 0.01% 178
2025
Q2
$990K Buy
12,508
+2,075
+20% +$165K 0.01% 174
2025
Q1
$936K Sell
10,433
-24,851
-70% -$2.32M 0.02% 170
2024
Q4
$3.51M Buy
35,284
+24,851
+238% +$2.56M 0.05% 105
2024
Q3
$1.18M Hold
10,433
0.02% 148
2024
Q2
$1.29M Sell
10,433
-955
-8% -$123K 0.02% 140
2024
Q1
$1.5M Buy
11,388
+8,687
+322% +$1.07M 0.03% 130
2023
Q4
$294K Buy
+2,701
New +$280K 0.01% 247

Other funds holding MRK

National Philanthropic Trust's MRK Position: Q2 2026 in Review

National Philanthropic Trust increased its Merck (MRK) stake by 2.3% in Q2 2026, buying an estimated $48.8K and bringing the position to 18,602 shares worth $2.39M. The position accounts for 0.03% of the portfolio, ranked #160.

National Philanthropic Trust first reported a position in MRK in Q4 2023 and has held it in 11 quarters since. The position peaked at $3.51M in Q4 2024. 3,688 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • National Philanthropic Trust held 18,602 shares of Merck worth $2.39M as of Q2 2026.
  • National Philanthropic Trust bought 417 Merck shares in Q2 2026, an estimated $48.8K.
  • Merck made up 0.03% of National Philanthropic Trust's portfolio in Q2 2026, its #160 holding.
  • National Philanthropic Trust first reported a position in Merck in Q4 2023 and has held it in 11 quarters since.
  • National Philanthropic Trust's Merck position peaked at $3.51M in Q4 2024.
  • 3,688 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on National Philanthropic Trust's 13F filing for Q2 2026, filed 14 Aug 2026.